Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Non-cash Items (2020 - 2021)

Historic Non-cash Items for Atea Pharmaceuticals (AVIR) over the last 2 years, with Q4 2021 value amounting to $31.2 million.

  • Atea Pharmaceuticals' Non-cash Items fell 8875.87% to $31.2 million in Q4 2021 from the same period last year, while for Dec 2021 it was $31.2 million, marking a year-over-year decrease of 8875.87%. This contributed to the annual value of $31.2 million for FY2021, which is 86222.2% up from last year.
  • Atea Pharmaceuticals' Non-cash Items amounted to $31.2 million in Q4 2021, which was down 8875.87% from $277.9 million recorded in Q4 2020.
  • Atea Pharmaceuticals' Non-cash Items' 5-year high stood at $277.9 million during Q4 2020, with a 5-year trough of $22.4 million in Q3 2020.